Three drugs may be better than one for certain patients with advanced colorectal cancer

(ECCO-the European CanCer Organisation) Patients with a form of advanced colorectal cancer that is driven by a mutated version of the BRAF gene have limited treatment options available. However, results, reported at the 26th EORTC-NCI-AACR Symposium, from a multi-center clinical trial suggest that the cancer may respond to a combination of three targeted drugs: encorafenib, cetuximab and alpelisib.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news